At a physiological level, we therefore view the current findings as evidence for a novel form of adaptive response [ 1] whereby maternal experience can lead to an increased level of postnatal tolerance which, within an anticipated pathogen-rich environment, would protect the offspring from the cytotoxic effects of their own frequent inflammatory responses.
From pilot data, we anticipated identifying a pathogen associated with the defined clinical syndromes in 50% of CNS cases, 60% of respiratory cases, 60% of enteric cases, and 30% of hepatitis cases; roughly 50 80% of these pathogens were predicted to be viruses.
Even though intervention measures are generally not needed in this stage, they are anticipated to combat a pathogen quickly when it occurs and are usually laid down in national contingency plans or equivalent regulations.
Negative regulation of Toll-like receptor-4 (TLR4) is anticipated to control the pathogen-induced exaggerated immune response.
Focal introduction of additional human pathogen-infected ticks is not anticipated to change transmission risk levels (scenarios 2 and 4).
Whereas resistance to Bt products was not anticipated, the development of resistance to other insect pathogens, such as viruses and fungi, in the field was considered even less likely.
We anticipated that growth profiles could illuminate correlations between a pathogen and its respective gene complements.
Contagious pathogens present singular operational challenges that must be anticipated in planning for mass casualty critical care.
However, given the pleomorphic nature of the pathogen and the failure of single component vaccines, it is anticipated that without a multi-component vaccine a significant reduction of disease burden will not be possible [ 8].
According to some recent studies [ 1, 7, 8], multiple pathogens are detected more frequently (up to 60% of cases) than anticipated before.
